Professional Documents
Culture Documents
Blood
Clear Fluid ( CSF): Beta Transferrin
Genitalia 1st LEVEL: EMERGENT
Endocrine Glands
Pituitary Gland
Adrenal Glands
Pancreas
Thyroid Glands
Parathyroid Glands
Gonads
The Hypothalamus:
- Skin
- Secreted by adenohypophysis
Beta- endorphins
Enkephalins
- Brain
- Secreted by adenohypophysis
- Ovaries or testes
- Secreted by adenohypophysis
Growth Hormone
Clinical Manifestations:
Initially: asymptomatic
3. Hypophysectomy
4. Radiation Therapy
NURSING INTERVENTIONS
- Hypotension
- Hypothermia
- Hyponatremia
- Hypoglycemia
- Bradycardia
- Respiratory Failure
GOALS OF CARE:
1. Recognizing and treating underlying
cause early
2. Maintaining normal Adrenal
Function
3. Preventing Complications ( infection
and hyperglycemia)
S/Sx of Cushing’s Syndrome:
- Weight gain especially in the trunk,
face, and neck ( Buffalo Hump)
- Muscle wasting of the extremities
and weakness
- Moon face and ruddy complexion
-
- Abdominal purple striae
- Hyperglycemia
- Electrolyte imbalance (HyperNa,
HypoKa)
- Emotional changes and depression
- Thin, Fragile Skin
- Female Virilization: Amenorrhea,
Hirsutism (Beard Hair), and Breast
Atrophy
Male: Gynecomastia
Complications of CUSHING’S:
1. Osteoporosis
2. Peptic Ulcer (from steroid intake)
3. Lipidosis
4. HPN and Impaired Glucose
Intolerance
5. Sexual Dysfunction
LABORATORY TESTS:
1. ACTH Levels: determine whether the
syndrome is ACTH dependent
2. Dexamethasone Suppression Test :
1mg dexamethasone given at 11PM
and serum cholesterol taken at 8AM
the next day.
- Cortisol level <5ug/dL excludes - Not enough glucocorticoids and
Cushing’s syndrome with 98% mineralocorticoids.
certainty
Etiology:
3. Radiologic Evaluation: tumor in the
pituitary gland or adrenal gland - In 3rd world countries: TB & HIV/AIDS
- In 1st world countries: autoimmune
NURSING INTERVENTIONS:
leads to atrophy, more common in
- Maintain muscle tone women than men
- Prevent accidents or falls and provide - Removal of glands, infection,
adequate rest neoplasm
- Protect client from exposure to
Secondary Addison’s Etiology:
infection
- Maintain skin integrity - Hypopituitarism may lead to ↓
- Minimize stress corticotropin secretion
- Monitor V/S ;WOF: HPN - Removal of non-endocrine
- Diet: LOW in calories, Sodium corticotropin- secreting tumor
HIGH in protein, Potassium, - Disorders in hypothalamic-pituitary
CA++, and Vitamin D function that diminish the production
- Monitor for urine glucose and of corticotropin
acetone, administer insulin if
necessary.
COLLABORATIVE MANAGEMENT:
1. Cytotoxic Agents
Eg: aminoglutethimide ( Cytaden)
trilostane (Modrastane)
mitotane ( Lysodren)
rationale: to decrease cortisol
production
2. HRT as needed
3. Prepare client for Adrenalectomy if
needed.
ADDISON’S DISEASE
- Aka adrenal hypofunction or adrenal
adrenocortical insufficiency
- Relatively uncommon but chronic
disorder that occurs in people of all
ages and in both sexes
S/Sx of ADDISON’s DISEASE IS THE PATIENT IN CRISIS?
- Confusion 1. ↑ K, Ca++ and BUN
- Fatigue 2. ↑ Hct, lymphocyte and eosinophil
- GI disturbances and wt loss 3. X-ray ( small heart and adrenal
- Hyperkalemia calcification)
- Bronze Pigmentation / tanning of the 4. ↓ Plasma cortisol levels ( <10mg/dl
skin in AM and lower levels at night)
- Hypoglycemia 5. ↓ Serum Na levels
- Postural Hypertension
- Muscle Weakness
- Px history will reveal synthetic
steroid use, adrenal surgery or recent
infection
WHAT TESTS WILL TELL YOU
1. Corticotropin level measurements
2. Rapid Corticotropin tests (ACTH
stimulation tests)
NATURE OF ADRENAL CRISIS
- A life-threatening complication of
addison’s Dse
- Critical deficiency of
mineralocorticoids and
glucocorticoids
- Emergency situation that requires
immediate, vigorous treatment
MANAGEMENT OF ADDISON’S DISEASE - Hypernatremia and Hypokalemia
(WOF: cardiac arrythmia)
1. Lifelong corticosteroid therapy
- Metabolic alkalosis
2. For crisis control:
- ↑ urine aldosterone level
- Prompt IV Bolus of 100mg
Hydrocortisone followed by LAB TESTS FOR CONN’S SYNDROME:
hydrocortisone diluted with
1. SCREENING TEST
dextrose in NSS and given until the
patient becomes stable.
a. PAC:PRA Ratio
NURSING INTERVENTIONS - the 1st test used in patients
suspected of having 1 ͦ
1. Administer Medications ( steroids)
hyperaldosteronism measures
as ordered
the plasma aldosterone
2. Monitor V/S
concentration (PAC) to plasma
3. Decrease stress in environment
renin activity (PRA) ratio.
4. Daily weight, I & O
- the levels of aldosterone and
5. Small frequent feedings
renin are measured in the blood.
DIET: HIGH in CHO, Na, and CHON
- a high ratio of PAC to PRA
Rationale: to prevent hypoglycemia
suggests 1 ͦ hyperaldosteronism;
and hyponatremia and provide
however, additional testing may
adequate nutrition.
be needed to confirm the
PRIMARY HYPERALDOSTERONISM diagnosis.
>Adult
/Extreme thirst
/Less frequent urination
/Dark-colored urine
/Fatigue
/Dizziness
/Confusion
Emergency Management: (for both DKA and
HHNC)
- Treat dehydration first with 0.9%
(Normal Saline) or 0.45% (half
strength saline)
Then: shift to D5W when glucose
level is down to 250-300mg/dL
WOF: too rapid correction, it can
cause rapid fluid shifts
( brain edema and increased ICP,
ARDS)
HYPERGLYCEMIC - Regular Insulin= 0.1 unit/kg bolus and
then 0.1 u/k/h drip
HYPEROSMOLAR NONKETOIC
Ex: 60kgs x 0.1 = amount of IV BOLUS
COMA (HHNC) - Correcting electrolyte imbalance
WOF: hypokalemia as a result of the
- Characterized by hyperglycemia and
treatment. WOF sever acidosis (pH <
a hyperosmolar state without ketosis
7.1 ), DKA patients may have to be
- Occurs in NIDDM people ( typically
given NaHC03
elderly people) who frequently has
high blood glucose (over 40mmol/L)
Precipitating Factors:
- Undiagnosed DM
- Infections or other stress
- Certain medications
- Dialysis
- Hyperalimentation (TPN)
- Major burns
Clinical Manifestations:
- Frequent vomiting
- Irritability
- Hyperactivity
- Unpredictable behavior
/ display bizarre, schizoid behavioral
pattern (screaming episodes, head
banging, arm biting, disorientation)
- Fright reaction
/ response to strong stimuli
(catatonic position)
CRISIS DISORDERS OF THE
NERVOUS SYSTEM
MYASTHENIA GRAVIS